•  
  •  
  •  
  •  

2026-03-06 19:32:45

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Ramky Infrastructure Wins ₹1,401.84 Crore Contract from Maharashtra Industrial Township Ltd for Dighi Port Industrial Area Project
  • Moneyboxx Finance Raises ₹33.4 Crore in Equity to Accelerate Growth and Strengthen Capital Base
  • Provigil Surveillance Ltd receives LOA for order worth Rs. 6.16 crore
  • Hannah Joseph Hospital receives award
  • Shree Refrigerations Ltd plans inauguration of new facility

Keywords Selected:  Pharmaceuticals

Research

  • CRISIL: Pharmaceutical sector set for 8-10% revenue growth this fiscal
  • Kotak Institutional Equities - Pharmaceuticals: IPM pulse - gaining momentum
  • Company Update - P&G Health - ICICI Direct
  • Quant Pick - Cadila Healthcare - ICICI Direct
  • Q2FY22 Result Update - Syngene International - ICICI Direct
  • Syngene International Ltd - Lack of near term triggers - YES Securities
  • Syngene International Ltd - Lower gross margin lead to EBIDTA miss - YES Securities

IPO News

  • Accretion Pharmaceuticals' IPO Opens for subscription today, Price Band set at ₹96-101 per Share
  • Accretion Pharmaceuticals Ltd IPO to open for subscription on May 14, 2025
  • Senores Pharmaceuticals IPO subscribed 13.93 times on Day 2
  • Senores Pharmaceuticals IPO fully subscribed on Day 1
  • Senores Pharmaceuticals gets Sebi nod for IPO

Stock Report

  • Eugia Pharma announces launch of Pomalidomide Capsules in the US
  • Gland Pharma Ltd receives tentative approval from USFDA
  • Glenmark Specialty SA Receives U.S. FDA Approval for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation, with 180-Day Competitive Generic Therapy Exclusivity
  • Smruthi Organics Ltd receives Attestation of Inspection from EDQM
  • Gland Pharma Limited announces resignation of CEO
  • NATCO announces launch of Pomalidomide Capsules (generic of Pomalyst&®) in the U.S. market
  • Ind-Swift Laboratories Earns EcoVadis Silver Medal for Sustainability Excellence
  • Emcure Pharmaceuticals and Roche Sign Distribution Agreement to Strengthen Nephrology and Transplant Care in India
  • Blue Jet Healthcare initiates Phase 1 of Vizag Manufacturing Facility
  • Caplin Steriles gets USFDA approval for Desmopressin Acetate Injection
  • Zydus receives final approvals from USFDA for Ivermectin Tablets USP, 3 mg and Dapsone Tablets USP, 25 mg and 100 mg
  • Completion of US FDA Inspection at Unit I of Eugia Pharma Specialities Ltd., Shameerpet
  • Zydus Lifesciences announces successful clinical development of Pembrolizumab biosimilar FYB206, marking a milestone toward USFDA filing
  • Lupin Receives EIR from US FDA for its Goa Facility
  • Glenmark Pharmaceuticals Inc., USA to launch Sodium Phosphates Injection USP, 15 mM P/5 mL, 45 mM P/15 mL and 150 mM P/50 mL (3 mM P/mL) Single-Dose Vials
  • Vinita Gupta, Lupin CEO, Named to the 2026 CNBC Changemakers List of Women Transforming Business for Making Medicines Accessible and Affordable for Americans
  • Aptus Pharma Ltd to expand into life saving injectables and ICU care products
  • Eugia Pharma receives USFDA Approval for Everolimus Tablets
  • Alembic Pharmaceuticals Limited announces USFDA Final Approval for Lamotrigine Orally Disintegrating Tablets USP, 25 mg, 50 mg, 100 mg and 200 mg
  • Zydus plans to launch innovative Semaglutide Injection in India on Day 1 of patent expiry
  • Infomerics Upgrade Fredun Pharmaceuticals Credit Rating to BBB+
  • Adita Bio Sys Pvt Ltd receives accreditation from the American Association for Laboratory Accreditation
  • Lupin announces the approval and launch of Brivaracetam Oral Solution in the United States
  • IOL Chemicals and Pharmaceuticals Ltd gets EDQM's CEP for API Clopidogrel Besilate

Industry News

  • NYSE Listed Amneal Pharmaceuticals begins Commercial Operations in India

Latest Post

  • Ramky Infrastructure Wins ₹1,401.84 Crore Contract from Maharashtra Industrial Township Ltd for Dighi Port Industrial Area Project
  • Moneyboxx Finance Raises ₹33.4 Crore in Equity to Accelerate Growth and Strengthen Capital Base
  • Provigil Surveillance Ltd receives LOA for order worth Rs. 6.16 crore
  • Hannah Joseph Hospital receives award
  • Shree Refrigerations Ltd plans inauguration of new facility


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025